TXG: Total Utang marang Modal 10x Genomics Corp

Simbol lan logo merek 10x (TXG)

Geopolitical tensions and export restrictions on high-tech equipment are narrowing the presence of 10x Genomics, Inc. (TXG) in Asian markets. Changes in the debt-to-equity ratio reflect the dynamics of the debt load, with the value stabilizing at 0.10. The company's strategy is shifting toward profit growth through reagent sales, leveraging a customer lock-in model within the sequencer ecosystem to create a stable cash cow.

TXG: Utang Agregat marang Modal 10x Genomics Inc 04.07.2022 - 31.10.2026

10x - rincian analitis lan metrik utama (TXG)

- rega lan prakiraan konsensus rega:
Bagan rega 10x Genomics|TXG - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar 10x Genomics|TXG - Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham 10x Genomics|TXG - Total Aset Bersih|Rasio Kapitalisasi marang Aset Bersih 10xgenomics.com|TXG - Total Aset Bisnis
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas 10x Genomics, Inc.|TXG - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal 10x Genomics, Inc.|TXG - Tanggungan utang total perusahaan|Utang-utang marang kapitalisasi buku 10x Genomics|TXG - Utang jangka dawa|Utang jangka cendhak perusahaan 10x Genomics|Likuiditas cepet 10xgenomics.com
- informasi bathi lan kelipatan valuasi:
TXG - Penghasilan resik perusahaan
Analisis kabeh metrik perusahaan:10x Genomics, TXG
Produk merek 10x

Investors are assessing the financial stability of 10x Genomics, Inc. (TXG) through its debt load level. This ratio is calculated as the sum of all liabilities divided by equity, determining the business's degree of dependence on borrowed funds. By analyzing the ratio of total financial debt to equity, one can evaluate the risk of bankruptcy. Low leverage is critically important for 10x Genomics, Inc. (TXG) amid US export restrictions and trade barriers with China. This provides the company with strategic autonomy in the event of a revenue decline.

Pesaing 10x Genomics, Inc.

Utang marang Ekuitas tempus.com|Rasio Utang marang Ekuitas QGEN (Qiagen NV)|Total Utang marang Modal IONS|Total Utang marang Modal Repligen Inc. (RGEN)|Total Utang marang Modal RNA (Avidity Biosciences)|Utang Agregat marang Modal CRSP (crisprtx.com)|WGS: Rasio Total Utang marang Ekuitas|RARE (Ultragenyx Pharmaceutical Inc.) - Rasio Utang marang Ekuitas|BEAM (Beam Therapeutics Corp) - Rasio Total Utang marang Ekuitas|Sarepta Corp - Rasio Kabeh Utang marang Dana Pribadi|TWST (Twist Bioscience) - Total Utang marang Modal|NTLA - Rasio Utang marang Modal|Total Utang marang Modal STOK|BLFS - Utang marang Modal|Utang marang Ekuitas Wave Life Sciences Corp WVE|MAZE: Rasio Utang marang Ekuitas|SION - Utang marang Ekuitas|Utang marang Modal primemedicine.com|Taysha Gene Therapies, Inc. (TSHA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas uniQure NV|MGTX (MeiraGTx PLC) - Total Utang marang Modal|REGENXBIO Corp (RGNX) - Koefisien Total Utang marang Modal|Total Utang marang Modal SLDB|Rasio Total Utang marang Ekuitas ocugen.com OCGN|Utang marang Ekuitas PacBio PACB|Koefisien Total Utang marang Modal Benitec Biopharma Inc (BNTC)|DSGN: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi RCKT (Rocket Corp)|FDMT: Total Utang marang Modal|LXEO - Koefisien Total Utang marang Modal|Utang marang Ekuitas Korro Bio Inc.|Rasio Utang marang Ekuitas EDIT (Editas Medicine Inc)|Total Utang marang Modal SLN|Rasio Total Utang marang Ekuitas proqr.com PRQR|Codexis - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal sangamo.com (SGMO)|NAUT: Rasio Total Utang marang Ekuitas|Metagenomi Inc. - Utang Agregat marang Modal|DTIL (Precision BioSciences, Inc.) - Rasio Total Utang marang Ekuitas|Rasio Utang marang Ekuitas GBIO|BOLD (Boundless Bio, Inc.) - Total Utang marang Modal|XCUR - Rasio Utang marang Modal|Total Utang marang Modal IMNN|phiopharma.com - Rasio Utang marang Ekuitas|Utang marang Ekuitas Mustang Bio MBIO|RNAZ: Rasio Utang marang Ekuitas|Bionano - Total Utang marang Modal|APDN - Total Utang marang Modal|BLUE: Total Utang marang Modal|IPA: Utang Agregat marang Modal|Rasio Total Utang marang Ekuitas OMGA|Rasio Utang marang Ekuitas OMIC (Singular Genomics Corp)|Rasio Total Utang marang Ekuitas RGLS (Regulus Therapeutics)|SYRS (syros.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal TBIO (Telesis Bio)|Rasio Utang marang Modal TRACON Pharmaceuticals Inc.|Unity Bio - Total Utang marang Modal